Annex Pharmaceutical & Chemicals Comprehensive Company Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 25-06-2024
- Paid Up Capital ₹ 1.00 Cr
as on 25-06-2024
- Company Age 18 Year, 4 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 2.85 Cr
as on 25-06-2024
- Satisfied Charges ₹ 6.39 Cr
as on 25-06-2024
- Revenue -3.59%
(FY 2020)
- Profit 56.15%
(FY 2020)
- Ebitda 46.98%
(FY 2020)
- Net Worth -172.33%
(FY 2020)
- Total Assets -5.57%
(FY 2020)
About Annex Pharmaceutical & Chemicals
The Company is engaged in the Chemicals And Resources Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹2.85 Cr. The company has closed loans amounting to ₹6.39 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sadruddin Khan, Sirajuddin Khan, and Sahabuddin Khan serve as directors at the Company.
- CIN/LLPIN
U24119MH2006PTC161700
- Company No.
161700
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 May 2006
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Annex Pharmaceutical & Chemicals Private Limited offer?
Annex Pharmaceutical & Chemicals Private Limited offers a wide range of products and services, including Chemical Plants & Machinery, Distillation Units, Dentist Tools, Equipment & Supplies, Dental Equipment, Storage Tanks, Drums & Containers, Drums.
Who are the key members and board of directors at Annex Pharmaceutical & Chemicals?
Board Members(3)
Financial Performance and Corporate Structure Insights of Annex Pharmaceutical & Chemicals.
Annex Pharmaceutical & Chemicals Private Limited, for the financial year ended 2020, experienced Minor drop in revenue, with a 3.59% decrease. The company also saw a substantial improvement in profitability, with a 56.15% increase in profit. The company's net worth observed a substantial decline by a decrease of 172.33%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Annex Pharmaceutical & Chemicals?
In 2020, Annex Pharmaceutical & Chemicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ramkamal Chemicals Private Limited
Active
28 years 2 months Sadruddin Khan, Sirajuddin Khan and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 03 Feb 2022 | ₹2.85 Cr | Open |
Dena Bank Creation Date: 22 Apr 2014 | ₹5.04 Cr | Satisfied |
Bank Of India Creation Date: 02 May 2013 | ₹6.00 M | Satisfied |
How Many Employees Work at Annex Pharmaceutical & Chemicals?
Unlock and access historical data on people associated with Annex Pharmaceutical & Chemicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
As of Mar 30, 2014, Annex Pharmaceutical & Chemicals has raised a total of ₹ 1.98 Cr, with the most recent deal valued at ₹ 7.5 M. Access detailed insights into the company’s deals, including security allotments, mergers, acquisitions, and strategic partnerships that have shaped its growth.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
